Chimeric Antigen Receptor T-Cell Therapies for Cancer

A Practical Guide

Authors:

Daniel W. Lee

Brand: Elsevier

ISBN: 9780323661812

PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 30 DAYS

402.51 zł

342.14 zł Save 60.37 zł Tax included

Lowest price within 30 days before promotion: 342.14 zł

Quantity

Available in 4-6 weeks

Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description

Chimeric Antigen Receptor (CAR) T-Cell Therapies for Cancer:: A Practical Guide presents a comprehensive view of CAR modified T-cells from patient referral to post-therapy management in a concise and practical format. Providing clinical guidance on the implementation and management of CAR T-cell therapy, this clinical resource keeps you up-to-date on the latest developments in this rapidly evolving area.

Product Details

Brand Elsevier

Reference 80868

EAN13 9780323661812

ISBN 9780323661812

Data sheet

Publication date: 2019
Issue number: 1
Cover: paperback
Pages count: 244
Dimensions (mm): 191 x 235
Weight (g): 500

Introduction 1. When to Refer a Patient for CAR-T Cell Therapy 2. Optimizing the Apheresis Product 3. CAR T Cells: Cell Processing Laboratory Considerations 4. Peri-CAR-T Cell Management 5. Management of Cytokine Release Syndrome 6. Special Considerations for ICU Management of Patients Receiving CAR Therapy 7. Neurotoxicities After CAR-T Cell Immunotherapy 8. Hematologic and Non-CRS Toxicities 9. Response Assessment and PosteCAR-T Cell Therapy Management 10. Relapse Management and Role for Consolidative Hematopoietic Stem Cell Transplantation Following CAR-T Cell Therapy 11. Promising Chimeric Antigen Receptors for Non-B Cell Hematological Malignancies, Pediatric Solid Tumors, and Carcinomas 12. CAR T Cell Therapy for CNS Malignancies 13. CAR 2.0: The Next Generation of Synthetic ReceptoreBased Cellular Therapy for Cancer